These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166 [TBL] [Abstract][Full Text] [Related]
7. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas. Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252 [TBL] [Abstract][Full Text] [Related]
8. Both location and age predict survival in ependymoma: a SEER study. McGuire CS; Sainani KL; Fisher PG Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249 [TBL] [Abstract][Full Text] [Related]
20. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients. Korshunov A; Golanov A; Sycheva R; Timirgaz V Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]